EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Amino acid–dependent TSC2 dephosphorylation by lysosome–PP2A regulates mTORC1 signaling transduction

Takanori Nakamura iD, Shigeyuki Nada iD, Masaki Matsumoto, Nuha Loling Othman, Hidetaka Kosako iD, Kazuki Ikeda iD, Naohiko Koshikawa, Junya Masumoto, Tatsuya Sawasaki, Mutsuhiro Takekawa iD, Takashi Suzuki, Masato Okada iD

Life Science Alliance · 2025

DOI: 10.26508/lsa.202503206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Alliance, 2025. Verfasst von Takanori Nakamura und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cell Signaling and Molecular Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, Japan nakamura.takanori.cb@ehime-u.a…. Hauptthemen laut MEDLINE: Mechanistic Target of Rapamycin Complex 1, Tuberous Sclerosis Complex 2 Protein, Amino Acids, Lysosomes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science, MEXT | JST | Core Research for Evolutional Science and Technology, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mammalian target of rapamycin complex 1 (mTORC1) signaling pathway, composed of amino acid (AA)–sensing (Ragulator/LAMTOR-Rag) and growth factor (GF)–sensing (AKT-TSC1/2-Rheb) axes, pivotally regulates intracellular anabolism and catabolism. mTORC1 deregulation is associated with various metabolic diseases, including cancer and diabetes. As a key regulator of nutrient signaling, mTORC1 integrates a variety of nutrient signals. However, signal integration and crosstalk in the mTORC1 pathway remain incompletely understood. Therefore, in this study, we aimed to understand the complex mTORC1 signaling cascade by constructing an integrated mathematical model of temporal mTORC1 regulation using two AA-sensing and GF-sensing axes. Mathematical simulations and experimental data revealed robust AKT phosphorylation (P-T308/P-S473) after insulin stimulation, regardless of the intracellular AA levels. Conversely, AKT-mediated inhibitory TSC2 phosphorylation (P-T1462) substantially diminished during AA deprivation compared with AA treatment. Furthermore, we highlighted PP2A-mediated TSC2 dephosphorylation during AA removal, ensuring complete mTORC1 activation only upon concurrent AA and GF sensing. Thus, we elucidated mTORC1 signaling dynamics, revealing the complex interplay between AAs and GFs and offering insights into metabolic regulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mechanistic Target of Rapamycin Complex 1Tuberous Sclerosis Complex 2 ProteinAmino AcidsLysosomesProtein Phosphatase 2PhosphorylationSignal TransductionHumansProto-Oncogene Proteins c-aktAnimalsInsulin

Substanzen

Mechanistic Target of Rapamycin Complex 1Tuberous Sclerosis Complex 2 ProteinAmino AcidsTSC2 protein, humanProto-Oncogene Proteins c-aktProtein Phosphatase 2Insulin

Autor:innen und Institutionen

  • Division of Cell Signaling and Molecular Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, Japan nakamura.takanori.cb@ehime-u.ac.jp.
  • Division of Cell-Free Sciences, Proteo-Science Center, Ehime University, Matsuyama, Japan.
  • Division of Pathology, Proteo-Science Center and Graduate School of Medicine, Ehime University, Toon, Japan.
  • Division of Informatics and Computation, Premier Institute for Advanced Studies, Ehime University, Matsuyama, Japan.
  • Department of Oncogene Research, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
  • Department of Omics and Systems Biology, Niigata University, Niigata, Japan.

ORCID-Profile: Takanori Nakamura, Shigeyuki Nada, Hidetaka Kosako, Kazuki Ikeda, Mutsuhiro Takekawa, Masato Okada

Förderung

  • MEXT | Japan Society for the Promotion of Science
  • MEXT | JST | Core Research for Evolutional Science and Technology
  • Japan Agency for Medical Research and Development
  • Takeda Science Foundation
  • Mochida Memorial Foundation for Medical and Pharmaceutical Research
  • Princess Takamatsu Cancer Research Fund

Zitieren

APA

Nakamura, T., Nada, S., Matsumoto, M., Loling Othman, N., Kosako, H., Ikeda, K., Koshikawa, N., Masumoto, J., Sawasaki, T., Takekawa, M., Suzuki, T., & Okada, M. (2025). Amino acid–dependent TSC2 dephosphorylation by lysosome–PP2A regulates mTORC1 signaling transduction. Life Science Alliance. https://doi.org/10.26508/lsa.202503206

Vancouver

Nakamura T, Nada S, Matsumoto M, Loling Othman N, Kosako H, Ikeda K, et al. Amino acid–dependent TSC2 dephosphorylation by lysosome–PP2A regulates mTORC1 signaling transduction. Life Science Alliance. 2025. doi:10.26508/lsa.202503206

BibTeX
@article{Nakamura2025,
  author = {Nakamura, Takanori and Nada, Shigeyuki and Matsumoto, Masaki and Loling Othman, Nuha and Kosako, Hidetaka and Ikeda, Kazuki and Koshikawa, Naohiko and Masumoto, Junya and Sawasaki, Tatsuya and Takekawa, Mutsuhiro and Suzuki, Takashi and Okada, Masato},
  title = {Amino acid–dependent TSC2 dephosphorylation by lysosome–PP2A regulates mTORC1 signaling transduction},
  journal = {Life Science Alliance},
  year = {2025},
  doi = {10.26508/lsa.202503206}
}
Kostenlos starten →